SCOTT BASS is the founder of the firm’s Global Life Sciences and Food and Drug Law practices in the United States, China and Europe. He provides seasoned strategic guidance on critical innovation, compliance and enforcement issues, including in the Good Manufacturing Practice (GMP), pharmacovigilance, promotion and litigation arenas. Scott has led the defense of many high-stakes criminal and civil investigations and audits, and he is also a qualified Mediator under New York State rules, bringing his deep global industry background to the dispute resolution table.
Using his experience as a lead drafter of the Dietary Supplement Health and Education Act, Scott has authored three books and is co-author of a recent New England Journal of Medicine article on necessary changes to that law. He advised U.S. FDA on its first dietary supplement website, and he serves as General Counsel to the global OTC drug association and as dietary supplement counsel to the association’s U.S. counterpart.
In China, Scott initiated the first life sciences practice, trained inspectors on GMP, and advised the Shanghai Institute for Food and Drug Safety in China on the formulation of new drug and device laws. He also served on a European Commission expert panel on food safety.
Scott is featured as a “Life Sciences Star” by LMG Life Sciences in both the FDA: Medical Devices and FDA: Pharmaceutical categories (2019–2022), and Benchmark Litigation has ranked him as a “Litigation Star” in Washington, D.C. (2022–2023). According to Chambers USA, “The ‘phenomenal’ Scott Bass leads the firm’s global life sciences group and is recognized for his strengths in the regulatory enforcement sphere, routinely handling investigations involving off-label promotion, fraud and abuse, and pharmacovigilance.” Clients say: “He is very available, very experienced and gives very wise advice.” He has received similar plaudits from other rating groups, including induction into the first LMG Life Sciences Hall of Fame.